Lilly to Invest €330 Million in New Biopharmaceutical Facility in Cork
Published on: Monday, 27 February 2012
The new facility, when fully operational, will require up to 200 highly skilled employees. In addition, a further 300 construction jobs will be created on the site during building works.
The planned 240,000-square-foot biopharmaceutical commercialisation and manufacturing facility announced today will further enhance the company’s ability to bring treatments for illnesses such as cancer and diabetes to patients worldwide. This is the second large investment Lilly has made at its Kinsale site in recent years. In 2006, the company announced a €300 million investment in its first biopharmaceutical manufacturing and new-product commercialisation facility at its Kinsale campus, which came on-stream in 2010.
for further information, see the IDA Ireland press release here.